Viewpoint: Battling antibiotic resistance requires ‘detection, prevention, innovation’ to counter rising threats

, | | December 12, 2019
a ce f aa e c ae a f f
Image: Rodolfo Parulan Jr./National Geographic
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The latest Antibiotic Resistance Threats Report, recently published by the Centers for Disease Control and Prevention, shows that antibiotic-resistant (AR) infections — when germs defeat the drugs designed to kill them — cause more than 35,000 deaths each year in the United States.

We continue to lead the U.S. public health response to combat antibiotic resistance through a three-pronged strategy: detection, prevention, and innovation. New data show our efforts over the past few years are saving lives. The new AR Threats Report finds an overall 18% reduction in deaths from antibiotic-resistant infections since the 2013 report, and a nearly 30% reduction in hospital deaths.

Related article:  Why the CDC’s opioid guidelines may be hurting patients in pain

Unfortunately, new data show that major challenges remain. The very nature of antibiotic resistance means that new threats are constantly emerging. Candida auris was not listed in the 2013 report because the world was not yet aware of its significance. Today, it is an urgent threat to the health of our nation and nations across the globe: More than 1 in 3 patients with invasive C. auris infection die. Rapid identification and response to this resistant fungus has been effective in many places, but we must remain vigilant to continue protecting Americans.

Read full, original post: U.S. continues to lead the fight against antibiotic resistance

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend